Free Trial
→ Arizona-made nanochips the new millionaire maker? (From Banyan Hill Publishing) (Ad)tc pixel Free FOLD Stock Alerts

Amicus Therapeutics (FOLD) SEC Filings & 10K Form

Amicus Therapeutics logo
$8.35 +0.19 (+2.33%)
Closing price 09/24/2025 04:00 PM Eastern
Extended Trading
$8.38 +0.04 (+0.42%)
As of 09/24/2025 07:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Amicus Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
08/25/2025
6:39 PM		Amicus Therapeutics (Issuer)
Harford Simon N.R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2025
6:01 AM		Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2025
3:53 PM		Amicus Therapeutics (Issuer)
ROBERTS EIRY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
3:54 PM		Amicus Therapeutics (Issuer)
Kelly Michael Aaron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
3:58 PM		Amicus Therapeutics (Issuer)
SBLENDORIO GLENN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
3:58 PM		Amicus Therapeutics (Issuer)
RAAB MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2025
8:30 AM		Amicus Therapeutics (Subject)
Avoro Capital Advisors LLC (Filed by)
Form SCHEDULE 13G/A
05/01/2025
6:00 AM		Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2025
5:00 AM		Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2025
4:01 PM		Amicus Therapeutics (Filer)
Form DEF 14A
04/24/2025
4:02 PM		Amicus Therapeutics (Filer)
Form DEFA14A
04/24/2025
4:03 PM		Amicus Therapeutics (Filer)
Form ARS
04/23/2025
7:14 PM		Amicus Therapeutics (Subject)
BlackRock, Inc. (Filed by)
Form SCHEDULE 13G/A
03/18/2025
4:56 PM		Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
6:27 PM		Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
6:01 AM		Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
7:00 PM		Amicus Therapeutics (Subject)
Redmile Group, LLC (Filed by)
Form SCHEDULE 13G/A
02/13/2025
4:14 PM		Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
4:17 PM		Amicus Therapeutics (Issuer)
Clark David Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
4:19 PM		Amicus Therapeutics (Issuer)
Castelli Jeff (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
4:22 PM		Amicus Therapeutics (Issuer)
Prout Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
4:00 PM		Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
9:25 AM		Amicus Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
01/13/2025
6:00 AM		Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2025
6:02 PM		Amicus Therapeutics (Issuer)
Harford Simon N.R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
6:03 PM		Amicus Therapeutics (Issuer)
Castelli Jeff (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
6:04 PM		Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
6:05 PM		Amicus Therapeutics (Issuer)
Clark David Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
6:06 PM		Amicus Therapeutics (Issuer)
Prout Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
6:06 PM		Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
5:12 PM		Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2024
3:43 PM		Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
8:00 PM		Amicus Therapeutics (Subject)
Redmile Group, LLC (Filed by)
Form SC 13G/A
11/14/2024
10:37 AM		Amicus Therapeutics (Subject)
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (Filed by)
Form SC 13G
11/14/2024
8:31 AM		Amicus Therapeutics (Subject)
Avoro Capital Advisors LLC (Filed by)
Form SC 13G/A
11/08/2024
9:52 AM		Amicus Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
11/07/2024
4:49 PM		Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
4:03 PM		Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2024
6:01 AM		Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
5:23 PM		Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
3:49 PM		Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/17/2024
6:00 AM		Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2024
12:24 PM		Amicus Therapeutics (Subject)
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Form SC 13G/A
10/04/2024
3:05 PM		Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
3:35 PM		Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:FOLD) was last updated on 9/25/2025 by MarketBeat.com Staff
From Our Partners
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...
Porter & Company | Sponsoredtc pixel
He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...
The Oxford Club | Sponsoredtc pixel
Stunning new initiative unfolding in the White House?
what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...
Paradigm Press | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
Out of 18,347 Cryptocurrencies... This is the ONLY One
The Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...
Crypto 101 Media | Sponsoredtc pixel
Capital Gains Tax Strategies for Seniors
Capital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...
SmartAsset | Sponsoredtc pixel
A New Way to Double Your Retirement Income?
Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...
Investors Alley | Sponsoredtc pixel
Strange crypto pattern discovered by 40-person research team
Something unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...
Crypto Swap Profits | Sponsoredtc pixel